Back to search
FDAFDA · Food and drugs·Recall number D-127-2013

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.

Published January 23, 2013 · Recall initiated: December 10, 2012

Summary

FDA records drug Class III recall D-127-2013, published January 23, 2013 and initiated December 10, 2012. Recalling firm: Upsher Smith Laboratories, Inc.; Status: Terminated; Reported quantity: 11,316 bottles; Lot: Lot #: 310162, Exp 09/14. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Upsher Smith Laboratories, Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot #: 310162, Exp 09/14
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11. recalled?

Yes. FDA published recall D-127-2013 on January 23, 2013. Reported hazard: Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone